Presentation slides and video from the 2018 Advances in Cancer Immunotherapy™ - Dallas, TX held on March 3, 2018 are available here.Program Organizers
Program SummarySpecifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, this program discussed:
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part B: Immune-Related Adverse Event (irAE) Management: Presentation: Identification and Management of irAEs in the Emergency Setting; Presenter: Robert Suter, DO, FAAEM - UT Southwestern Medical Center; Date: March 3, 201800:36:53
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Basic Principles of Cancer Immunotherapy; Presenter: Joseph W. Fay, MD - Fay Foundation; Date: March 3, 201800:34:55
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part B: Immune-Related Adverse Event (irAE) Management: Presentation: Management and Mitigation of irAEs for Immunotherapy Prescribers; Presenter: Saad A. Khan, MD - UT Southwestern Medical Center; Date: March 3, 201800:29:04
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy into Community Practice: Presentation: Coverage and Reimbursement Challenges and Strategies; Presenter: Jeff Liticker, RPh, PharmD, BCOP - UT Southwestern Medical Center; Date: March 3, 201800:33:59
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part B: Immune-Related Adverse Event (irAE) Management: Presentation: Mechanisms of Immune-Related Adverse Events; Presenter: Rolf A. Brekken, PhD - UT Southwestern Medical Center; Date: March 3, 201800:19:57
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part B: Immune-Related Adverse Event (irAE) Management: Presentation: Nursing Perspective on irAEs: Patient Education, Monitoring and Management; Presenter: Michele G. Suter, MSN, FNP-C - McKenney Clinic; Date: March 3, 201800:26:43
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy into Community Practice: Presentation: Effective Practices for Incorporating Immunotherapy into Hospital Operations; Presenter: Sanjiv S. Agarwala, MD - St. Luke's Cancer Center and Temple University; Date: March 3, 201800:24:55
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Hematologic Malignancies; Presenter: Larry Anderson, MD, PhD - UT Southwestern Medical Center; Date: March 3, 201800:20:25
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Genitourinary Cancer; Presenter: Isaac A. Bowman, MD - UT Southwestern Medical Center; Date: March 3, 201800:23:21
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Jade Homsi, MD - UT Southwestern Medical Center; Date: March 3, 201800:21:33
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Lung Cancer; Presenter: James Kim, MD, PhD - UT Southwestern Medical Center; Date: March 3, 201800:18:59
Meeting: Advances in Cancer Immunotherapy™- Dallas, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Head and Neck Cancers; Presenter: Saad A. Khan, MD - UT Southwestern Medical Center; Date: March 3, 201800:17:54
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us